200 related articles for article (PubMed ID: 26255795)
1. Small Molecules in the Treatment of Psoriasis.
Torres T; Filipe P
Drug Dev Res; 2015 Aug; 76(5):215-27. PubMed ID: 26255795
[TBL] [Abstract][Full Text] [Related]
2. New drugs and treatment targets in psoriasis.
Kofoed K; Skov L; Zachariae C
Acta Derm Venereol; 2015 Feb; 95(2):133-9. PubMed ID: 25111317
[TBL] [Abstract][Full Text] [Related]
3. New therapies under development for psoriasis treatment.
García-Pérez ME; Stevanovic T; Poubelle PE
Curr Opin Pediatr; 2013 Aug; 25(4):480-7. PubMed ID: 23838833
[TBL] [Abstract][Full Text] [Related]
4. Amygdalin analogs for the treatment of psoriasis.
Perez JJ
Future Med Chem; 2013 May; 5(7):799-808. PubMed ID: 23651093
[TBL] [Abstract][Full Text] [Related]
5. Topical therapy for psoriasis: a promising future. Focus on JAK and phosphodiesterase-4 inhibitors.
Rafael A; Torres T
Eur J Dermatol; 2016; 26(1):3-8. PubMed ID: 26552963
[TBL] [Abstract][Full Text] [Related]
6. A new therapeutic for the treatment of moderate-to-severe plaque psoriasis: apremilast.
Chiricozzi A; Caposiena D; Garofalo V; Cannizzaro MV; Chimenti S; Saraceno R
Expert Rev Clin Immunol; 2016; 12(3):237-49. PubMed ID: 26692125
[TBL] [Abstract][Full Text] [Related]
7. Molecular Mechanisms and Management of a Cutaneous Inflammatory Disorder: Psoriasis.
Woo YR; Cho DH; Park HJ
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29232931
[TBL] [Abstract][Full Text] [Related]
8. Advances in treating psoriasis in the elderly with small molecule inhibitors.
Cline A; Cardwell LA; Feldman SR
Expert Opin Pharmacother; 2017 Dec; 18(18):1965-1973. PubMed ID: 29171774
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis.
Bianchi L; Del Duca E; Romanelli M; Saraceno R; Chimenti S; Chiricozzi A
Expert Opin Drug Metab Toxicol; 2016 Sep; 12(9):1121-8. PubMed ID: 27376729
[TBL] [Abstract][Full Text] [Related]
10. [Use of biologicals in psoriasis].
Friedrich M; Philipp S; Sabat R; Asadullah K; Sterry W
Z Rheumatol; 2003 Oct; 62(5):439-49. PubMed ID: 14579031
[TBL] [Abstract][Full Text] [Related]
11. The status of biologic therapies in the treatment of moderate to severe psoriasis.
Menter A
Cutis; 2009 Oct; 84(4 Suppl):14-24. PubMed ID: 19916298
[TBL] [Abstract][Full Text] [Related]
12. Emerging systemic drugs in the treatment of plaque psoriasis.
Balogh EA; Bashyam AM; Ghamrawi RI; Feldman SR
Expert Opin Emerg Drugs; 2020 Jun; 25(2):89-100. PubMed ID: 32192366
[TBL] [Abstract][Full Text] [Related]
13. Emerging topical treatments for psoriasis.
Kivelevitch DN; Hebeler KR; Patel M; Menter A
Expert Opin Emerg Drugs; 2013 Dec; 18(4):523-32. PubMed ID: 24274614
[TBL] [Abstract][Full Text] [Related]
14. Anti-TNF agents for the treatment of psoriasis.
Kircik LH; Del Rosso JQ
J Drugs Dermatol; 2009 Jun; 8(6):546-59. PubMed ID: 19537380
[TBL] [Abstract][Full Text] [Related]
15. Tofacitinib and other kinase inhibitors in the treatment of psoriasis.
Ortiz-Ibáñez K; Alsina MM; Muñoz-Santos C
Actas Dermosifiliogr; 2013 May; 104(4):304-10. PubMed ID: 23583515
[TBL] [Abstract][Full Text] [Related]
16. Novel systemic therapies for the treatment of psoriasis.
Tan KW; Griffiths CE
Expert Opin Pharmacother; 2016; 17(1):79-92. PubMed ID: 26548897
[TBL] [Abstract][Full Text] [Related]
17. Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach.
Späh F
Br J Dermatol; 2008 Aug; 159 Suppl 2():10-7. PubMed ID: 18700910
[TBL] [Abstract][Full Text] [Related]
18. Long-term data in the treatment of psoriasis.
Thaçi D
Br J Dermatol; 2008 Aug; 159 Suppl 2():18-24. PubMed ID: 18700911
[TBL] [Abstract][Full Text] [Related]
19. Small molecules to the rescue: Inhibition of cytokine signaling in immune-mediated diseases.
Gadina M; Gazaniga N; Vian L; Furumoto Y
J Autoimmun; 2017 Dec; 85():20-31. PubMed ID: 28676205
[TBL] [Abstract][Full Text] [Related]
20. Emerging Oral Therapies for the Treatment of Psoriasis: A Review of Pipeline Agents.
Drakos A; Torres T; Vender R
Pharmaceutics; 2024 Jan; 16(1):. PubMed ID: 38258121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
